Logo image of VALUE.AS

VALUE8 NV (VALUE.AS) Stock Fundamental Analysis

AMS:VALUE - Euronext Amsterdam - NL0010661864 - Common Stock - Currency: EUR

6.65  +0.1 (+1.53%)

Fundamental Rating

6

Taking everything into account, VALUE scores 6 out of 10 in our fundamental rating. VALUE was compared to 109 industry peers in the Capital Markets industry. VALUE has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. VALUE has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

VALUE had positive earnings in the past year.
In the past year VALUE had a positive cash flow from operations.
VALUE had positive earnings in 4 of the past 5 years.
Of the past 5 years VALUE 4 years had a positive operating cash flow.
VALUE.AS Yearly Net Income VS EBIT VS OCF VS FCFVALUE.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

1.2 Ratios

VALUE has a better Return On Assets (6.49%) than 80.73% of its industry peers.
VALUE's Return On Equity of 6.93% is in line compared to the rest of the industry. VALUE outperforms 50.46% of its industry peers.
Looking at the Return On Invested Capital, with a value of 5.25%, VALUE is in the better half of the industry, outperforming 70.64% of the companies in the same industry.
Industry RankSector Rank
ROA 6.49%
ROE 6.93%
ROIC 5.25%
ROA(3y)3.11%
ROA(5y)8.36%
ROE(3y)3.39%
ROE(5y)9.25%
ROIC(3y)N/A
ROIC(5y)N/A
VALUE.AS Yearly ROA, ROE, ROICVALUE.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20 25

1.3 Margins

VALUE has a better Profit Margin (76.60%) than 94.50% of its industry peers.
In the last couple of years the Profit Margin of VALUE has grown nicely.
VALUE has a Operating Margin of 79.24%. This is amongst the best in the industry. VALUE outperforms 94.50% of its industry peers.
VALUE's Operating Margin has improved in the last couple of years.
VALUE has a better Gross Margin (87.04%) than 84.40% of its industry peers.
VALUE's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 79.24%
PM (TTM) 76.6%
GM 87.04%
OM growth 3Y-4.34%
OM growth 5Y3.23%
PM growth 3Y-4.58%
PM growth 5Y3.86%
GM growth 3Y-2.94%
GM growth 5Y0.39%
VALUE.AS Yearly Profit, Operating, Gross MarginsVALUE.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200 300

9

2. Health

2.1 Basic Checks

Compared to 1 year ago, VALUE has about the same amount of shares outstanding.
The number of shares outstanding for VALUE has been reduced compared to 5 years ago.
VALUE has a better debt/assets ratio than last year.
VALUE.AS Yearly Shares OutstandingVALUE.AS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
VALUE.AS Yearly Total Debt VS Total AssetsVALUE.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

VALUE has an Altman-Z score of 6.49. This indicates that VALUE is financially healthy and has little risk of bankruptcy at the moment.
VALUE has a better Altman-Z score (6.49) than 90.83% of its industry peers.
The Debt to FCF ratio of VALUE is 2.13, which is a good value as it means it would take VALUE, 2.13 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of VALUE (2.13) is better than 88.07% of its industry peers.
VALUE has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of VALUE (0.02) is better than 85.32% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 2.13
Altman-Z 6.49
ROIC/WACCN/A
WACCN/A
VALUE.AS Yearly LT Debt VS Equity VS FCFVALUE.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

A Current Ratio of 5.10 indicates that VALUE has no problem at all paying its short term obligations.
VALUE has a better Current ratio (5.10) than 88.07% of its industry peers.
VALUE has a Quick Ratio of 5.10. This indicates that VALUE is financially healthy and has no problem in meeting its short term obligations.
VALUE has a Quick ratio of 5.10. This is amongst the best in the industry. VALUE outperforms 88.07% of its industry peers.
Industry RankSector Rank
Current Ratio 5.1
Quick Ratio 5.1
VALUE.AS Yearly Current Assets VS Current LiabilitesVALUE.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

3

3. Growth

3.1 Past

VALUE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 29.66%, which is quite impressive.
The Earnings Per Share has been growing by 10.04% on average over the past years. This is quite good.
Looking at the last year, VALUE shows a quite strong growth in Revenue. The Revenue has grown by 15.77% in the last year.
VALUE shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.58% yearly.
EPS 1Y (TTM)29.66%
EPS 3Y-27.89%
EPS 5Y10.04%
EPS Q2Q%-145.06%
Revenue 1Y (TTM)15.77%
Revenue growth 3Y-23.62%
Revenue growth 5Y5.58%
Sales Q2Q%-113.35%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
VALUE.AS Yearly Revenue VS EstimatesVALUE.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

4

4. Valuation

4.1 Price/Earnings Ratio

VALUE is valuated reasonably with a Price/Earnings ratio of 8.99.
Compared to the rest of the industry, the Price/Earnings ratio of VALUE indicates a rather cheap valuation: VALUE is cheaper than 86.24% of the companies listed in the same industry.
VALUE is valuated cheaply when we compare the Price/Earnings ratio to 27.45, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 8.99
Fwd PE N/A
VALUE.AS Price Earnings VS Forward Price EarningsVALUE.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, VALUE is valued a bit cheaper than 77.06% of the companies in the same industry.
Industry RankSector Rank
P/FCF 24.75
EV/EBITDA -0.78
VALUE.AS Per share dataVALUE.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

VALUE has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.89
EPS Next 2YN/A
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

VALUE has a Yearly Dividend Yield of 2.95%.
VALUE's Dividend Yield is a higher than the industry average which is at 5.70.
Compared to an average S&P500 Dividend Yield of 2.42, VALUE pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.95%

5.2 History

The dividend of VALUE decreases each year by -33.59%.
Dividend Growth(5Y)-33.59%
Div Incr Years3
Div Non Decr Years3
VALUE.AS Yearly Dividends per shareVALUE.AS Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 0.2 0.4 0.6 0.8 1

5.3 Sustainability

18.96% of the earnings are spent on dividend by VALUE. This is a low number and sustainable payout ratio.
DP18.96%
EPS Next 2YN/A
EPS Next 3YN/A
VALUE.AS Yearly Income VS Free CF VS DividendVALUE.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M
VALUE.AS Dividend Payout.VALUE.AS Dividend Payout, showing the Payout Ratio.VALUE.AS Dividend Payout.PayoutRetained Earnings

VALUE8 NV

AMS:VALUE (7/3/2025, 7:00:00 PM)

6.65

+0.1 (+1.53%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners68.24%
Ins Owner ChangeN/A
Market Cap61.84M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.95%
Yearly Dividend0.14
Dividend Growth(5Y)-33.59%
DP18.96%
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 8.99
Fwd PE N/A
P/S 6.64
P/FCF 24.75
P/OCF 24.75
P/B 0.6
P/tB 0.6
EV/EBITDA -0.78
EPS(TTM)0.74
EY11.13%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.27
FCFY4.04%
OCF(TTM)0.27
OCFY4.04%
SpS1
BVpS11.08
TBVpS11.08
PEG (NY)N/A
PEG (5Y)0.89
Profitability
Industry RankSector Rank
ROA 6.49%
ROE 6.93%
ROCE 7.16%
ROIC 5.25%
ROICexc 7.92%
ROICexgc 7.92%
OM 79.24%
PM (TTM) 76.6%
GM 87.04%
FCFM 26.82%
ROA(3y)3.11%
ROA(5y)8.36%
ROE(3y)3.39%
ROE(5y)9.25%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-32.33%
ROICexcg growth 5Y0.56%
ROICexc growth 3Y-32.33%
ROICexc growth 5Y0.59%
OM growth 3Y-4.34%
OM growth 5Y3.23%
PM growth 3Y-4.58%
PM growth 5Y3.86%
GM growth 3Y-2.94%
GM growth 5Y0.39%
F-Score7
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 2.13
Debt/EBITDA 0.31
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 19.07
Cash Conversion 33.28%
Profit Quality 35.02%
Current Ratio 5.1
Quick Ratio 5.1
Altman-Z 6.49
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)29.66%
EPS 3Y-27.89%
EPS 5Y10.04%
EPS Q2Q%-145.06%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)15.77%
Revenue growth 3Y-23.62%
Revenue growth 5Y5.58%
Sales Q2Q%-113.35%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y17.03%
EBIT growth 3Y-26.93%
EBIT growth 5Y8.99%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y320.71%
FCF growth 3Y14.54%
FCF growth 5Y-28.23%
OCF growth 1Y320.71%
OCF growth 3Y14.54%
OCF growth 5Y-28.23%